InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Wave Life Sciences, Inc.

WVE Clue Score51
United States Fiscal year ends December CIK 0001631574 Results filed 27 Oct 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

74
Insider
Date
Role
Action
Shares
Price
Amount
Heidi L Wagner
11 Aug 2026
Director
Sold after exercise
7,000
$6.01
$42.07K
Chris Francis
26 Feb 2026
See Remarks
Sold after exercise
15,294
$15.00
$229.41K
Chris Francis
26 Feb 2026
See Remarks
Sold after exercise
17,900
$15.09
$270.18K
Chris Francis
2 Jan 2026
See Remarks
Sold after exercise
1,295
$16.70
$21.63K
Chris Francis
2 Jan 2026
See Remarks
Sold after exercise
8,080
$15.92
$128.63K
Kyle Moran
9 Dec 2025
Chief Financial Officer
Sold after exercise
50,000
$20.03
$1.00M
Kyle Moran
9 Dec 2025
Chief Financial Officer
Sold after exercise
36
$20.25
$729.00
Kyle Moran
8 Dec 2025
Chief Financial Officer
Sold after exercise
50,000
$18.00
$900.00K
Kyle Moran
8 Dec 2025
Chief Financial Officer
Sold after exercise
50,000
$13.20
$660.00K
Kyle Moran
8 Dec 2025
Chief Financial Officer
Sold after exercise
50,000
$15.00
$750.00K
Kyle Moran
8 Dec 2025
Chief Financial Officer
Sold after exercise
60,000
$13.20
$792.00K
Chris Francis
8 Dec 2025
See Remarks
Sold after exercise
22,500
$14.08
$316.80K
Chris Francis
8 Dec 2025
See Remarks
Sold after exercise
50,000
$16.00
$800.00K
Chris Francis
8 Dec 2025
See Remarks
Sold after exercise
122,349
$14.20
$1.74M
Chris Francis
8 Dec 2025
See Remarks
Sold after exercise
17,900
$15.00
$268.50K
Chris Francis
8 Dec 2025
See Remarks
Sold after exercise
37,500
$14.08
$528.00K
Chris Francis
8 Dec 2025
See Remarks
Sold after exercise
9,375
$15.00
$140.63K
Chris Francis
8 Dec 2025
See Remarks
Sold after exercise
45,882
$14.50
$665.29K
Chris Francis
8 Dec 2025
See Remarks
Sold after exercise
107,400
$14.56
$1.56M
Chris Francis
8 Dec 2025
See Remarks
Sold after exercise
28,125
$14.50
$407.81K
Aik Na Tan
8 Dec 2025
Director
Sold after exercise
21,000
$12.75
$267.75K
Aik Na Tan
8 Dec 2025
Director
Sold after exercise
21,000
$12.75
$267.75K
Aik Na Tan
8 Dec 2025
Director
Sold after exercise
25,000
$15.00
$375.00K
Aik Na Tan
8 Dec 2025
Director
Sold after exercise
20,000
$12.75
$255.00K
Aik Na Tan
8 Dec 2025
Director
Sold after exercise
17,230
$15.00
$258.45K
Aik Na Tan
8 Dec 2025
Director
Sold after exercise
15,000
$12.75
$191.25K
Aik Na Tan
8 Dec 2025
Director
Sold after exercise
7,494
$15.00
$112.41K
Aik Na Tan
8 Dec 2025
Director
Sold after exercise
7,494
$12.75
$95.55K
Christian O Henry
8 Dec 2025
Director
Sold after exercise
30,000
$18.02
$540.60K
Christian O Henry
8 Dec 2025
Director
Sold after exercise
15,000
$14.07
$211.05K
Christian O Henry
8 Dec 2025
Director
Sold after exercise
42,000
$12.75
$535.50K
Christian O Henry
8 Dec 2025
Director
Sold after exercise
6,445
$12.75
$82.17K
Heidi L Wagner
8 Dec 2025
Director
Sold after exercise
7,000
$14.00
$98.00K
Heidi L Wagner
8 Dec 2025
Director
Sold after exercise
7,000
$13.00
$91.00K
Adrian Rawcliffe
8 Dec 2025
Director
Sold after exercise
42,000
$15.00
$630.00K
Aik Na Tan
15 Aug 2025
Director
Sold after exercise
21,000
$9.25
$194.25K
Christian O Henry
20 Mar 2025
Director
Sold after exercise
10,500
$9.77
$102.57K
Paul Bolno
7 Mar 2025
President and CEO
Sold after exercise
169,025
$9.57
$1.62M
Paul Bolno
25 Nov 2024
President and CEO
Sold after exercise
50,000
$15.00
$750.00K
Chris Francis
8 Nov 2024
See Remarks
Sold after exercise
36,000
$16.00
$576.00K
Chris Francis
16 Oct 2024
See Remarks
Sold after exercise
22,500
$13.50
$303.75K
Chris Francis
16 Oct 2024
See Remarks
Sold after exercise
65,625
$13.75
$902.34K
Chris Francis
16 Oct 2024
See Remarks
Sold after exercise
40,997
$13.00
$532.96K
Chris Francis
16 Oct 2024
See Remarks
Sold after exercise
79,714
$14.00
$1.12M
Paul Bolno
15 Sep 2020
President and CEO
Sold after exercise
100,000
$15.00
$1.50M
Paul Bolno
25 Aug 2020
President and CEO
Sold after exercise
25,000
$12.00
$300.00K
Paul Bolno
2 Jul 2020
President and CEO
Sold after exercise
95,921
$10.27
$985.11K
Paul Bolno
2 Jul 2020
President and CEO
Sold after exercise
4,079
$10.91
$44.50K
Paul Bolno
2 Jul 2020
President and CEO
Sold after exercise
43,068
$10.26
$441.88K
Paul Bolno
2 Jul 2020
President and CEO
Sold after exercise
4,509
$10.82
$48.79K
Chandra Vargeese
3 Dec 2019
Senior VP, Drug Discovery
Sold after exercise
6,000
$35.00
$210.00K
Paul Bolno
15 Mar 2019
President and CEO
Sold after exercise
1,763
$46.00
$81.10K
Paul Bolno
15 Mar 2019
President and CEO
Sold after exercise
8,237
$45.22
$372.48K
Paul Bolno
15 Mar 2019
President and CEO
Sold after exercise
5,065
$45.89
$232.43K
Paul Bolno
15 Mar 2019
President and CEO
Sold after exercise
34,935
$45.45
$1.59M
Chris Francis
25 Sep 2018
See Remarks
Sold after exercise
10,543
$56.00
$590.41K
Chandra Vargeese
24 Sep 2018
Senior VP, Drug Discovery
Sold after exercise
3,000
$55.00
$165.00K
Keith Regnante
24 Sep 2018
Chief Financial Officer
Sold after exercise
29,500
$55.00
$1.62M
Chris Francis
24 Sep 2018
See Remarks
Sold after exercise
1,032
$56.00
$57.79K
Chris Francis
9 Jul 2018
See Remarks
Sold after exercise
596
$38.22
$22.78K
Chris Francis
9 Jul 2018
See Remarks
Sold after exercise
23,900
$37.25
$890.28K
Chris Francis
1 Jun 2018
See Remarks
Sold after exercise
24,496
$48.00
$1.18M
Paul Bolno
30 May 2018
President and CEO
Sold after exercise
20,250
$45.00
$911.25K
Chris Francis
30 May 2018
See Remarks
Sold after exercise
24,496
$45.50
$1.11M
Paul Bolno
29 May 2018
President and CEO
Sold after exercise
3,145
$45.00
$141.53K
Paul Bolno
25 May 2018
President and CEO
Sold after exercise
8,316
$45.00
$374.22K
Paul Bolno
2 May 2018
President and CEO
Sold after exercise
18,289
$45.00
$823.01K
Chris Francis
20 Feb 2018
See Remarks
Sold after exercise
11,504
$55.95
$643.65K
Chris Francis
16 Feb 2018
See Remarks
Sold after exercise
9,412
$55.00
$517.66K
Chris Francis
16 Feb 2018
See Remarks
Sold after exercise
723
$51.80
$37.45K
Michael A. Panzara
15 Feb 2018
Franchise Lead, Neurology
Sold after exercise
18,750
$50.00
$937.50K
Chandra Vargeese
15 Feb 2018
See Remarks
Sold after exercise
2,000
$50.00
$100.00K
Chandra Vargeese
23 Jan 2018
See Remarks
Sold after exercise
2,000
$40.00
$80.00K
Chandra Vargeese
22 Nov 2017
See Remarks
Sold after exercise
1,500
$35.00
$52.50K
Show all 166 transactions →

What was left out

Form 4 filings counted 234
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 15
Sales on a Rule 10b5-1 plan 20
Sales straight out of an exercise 74
Sales at will 50
Transactions with no price 0
Shares from compensation/vesting 9,171,525
Sales filed before the plan box existed 46
History held since 18 Nov 2015